Samorita Hospital Income Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Revenue	426.58	401.37	378.39	334.27	338.09	393.62
Revenue Growth (YoY)	9.15%	6.07%	13.20%	-1.13%	-14.11%	22.53%
Cost of Revenue	178.7	177.07	162.67	145.76	148.05	172.75
Gross Profit	247.88	224.29	215.72	188.5	190.04	220.87
Selling, General & Admin	203.57	181.38	170.38	157.9	141.97	147.25
Other Operating Expenses	0.8	0.8	0.82	1.87	0.64	0.12
Operating Expenses	229.63	207.39	198.15	184.72	165.63	171.7
Operating Income	18.25	16.9	17.57	3.78	24.41	49.17
Interest Expense	-2.47	-2.76	-5.44	-6.05	-6.93	-
Interest & Investment Income	1.65	1.36	2.08	2.44	3.67	4.04
Earnings From Equity Investments	0.12	0.1	0.04	0.04	0.04	-0.07
Other Non Operating Income (Expenses)	3.82	2.68	2.48	2.86	2.84	1.46
EBT Excluding Unusual Items	21.36	18.27	16.73	3.07	24.03	54.61
Gain (Loss) on Sale of Assets	-0.23	-0.23	0.18	0.03	0.31	-0.07
Pretax Income	21.14	18.05	16.92	3.1	24.34	54.53
Income Tax Expense	10.41	4.52	4.72	2.38	8.04	12.44
Net Income	10.73	13.53	12.2	0.72	16.29	42.09
Net Income to Common	10.73	13.53	12.2	0.72	16.29	42.09
Net Income Growth	-7.81%	10.91%	1593.40%	-95.58%	-61.29%	1193.89%
Shares Outstanding (Basic)	22	22	22	22	22	22
Shares Outstanding (Diluted)	22	22	22	22	22	22
EPS (Basic)	0.49	0.62	0.56	0.03	0.75	1.93
EPS (Diluted)	0.49	0.62	0.56	0.03	0.75	1.93
EPS Growth	-7.81%	10.91%	1593.42%	-95.58%	-61.29%	1193.89%
Free Cash Flow	20	16.41	26.65	-0.04	-11.26	-21.62
Free Cash Flow Per Share	0.92	0.75	1.22	-0.00	-0.52	-0.99
Dividend Per Share	0.500	0.500	0.500	-	0.433	0.866
Dividend Growth	-	-	-	-	-50.00%	-
Gross Margin	58.11%	55.88%	57.01%	56.39%	56.21%	56.11%
Operating Margin	4.28%	4.21%	4.64%	1.13%	7.22%	12.49%
Profit Margin	2.51%	3.37%	3.22%	0.22%	4.82%	10.69%
Free Cash Flow Margin	4.69%	4.09%	7.04%	-0.01%	-3.33%	-5.49%
EBITDA	42.24	40.9	41.22	26.82	44.27	69.81
EBITDA Margin	9.90%	10.19%	10.89%	8.02%	13.09%	17.74%
D&A For EBITDA	24	24	23.65	23.04	19.86	20.64
EBIT	18.25	16.9	17.57	3.78	24.41	49.17
EBIT Margin	4.28%	4.21%	4.64%	1.13%	7.22%	12.49%
Effective Tax Rate	49.24%	25.02%	27.88%	76.76%	33.06%	22.82%
Advertising Expenses	-	0.77	1.03	1.02	0.93	1.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.